Siemens Healthineers shakes up leadership team, cuts profit outlook

Siemens Healthineers is shaking up its leadership team, coinciding with the company also cutting its profit outlook for 2026 amid market challenges. 

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on Thursday, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. Siemens Healthineers said this was prompted primarily by “structural change” in the China market. 

The republic—which accounts for 10% of the company’s revenue, second after the U.S.—has been impacted by lower reimbursement rates and volume-based device procurement that depressed prices, Reuters noted.

“While the environment remains tough, our synergetic core of imaging and precision therapy is on track with good momentum,” CEO Bernd Montag, PhD, said in a statement May 7. “We are also taking measures for the future of the company by initiating the next steps to create options for diagnostics and introducing an evolution of the leadership team.”

As a result of challenges in China and “more pronounced inflation assumptions,” Siemens Healthineers is updating its fiscal outlook. Leaders are now anticipating comparable revenue growth of between 4.5% and 5% for fiscal 2025 (down from 5% to 6%). And for adjusted basic earnings per share, they’re now expecting a range of between $2.58 to $2.70 (compared to the previous estimate of $2.58 to $2.82). 

Montag shared further details about the leadership changes in a LinkedIn post published Thursday. On June 1, Andreas Schneck will take over as head of diagnostic imaging, succeeding André Hartung, “who has decided to leave the company after 25 years to pursue other opportunities.” Schneck has held leadership roles across both diagnostic and interventional imaging, including piloting the magnetic resonance imaging business in Shenzhen, China, from 2020–2023 and the global MRI business for the past three years. The CEO touted accomplishments under Schneck’s tenure that included significantly expanding market share in diagnostic imaging and introducing breakthroughs such as photon-counting CT and dry-cool MR magnet technology. 

“Andre had a key role in helping us adopt a clinical conditions mindset, preparing the path to our Elevating Health Globally strategy,” Montag wrote. “We sincerely thank Andre for his many years of dedication and impact.”

Meanwhile, Philipp Fischer will become head of advanced therapies for Siemens Healthineers on June 1. He succeeds the retiring Carsten Bertram, who will support the company’s new chief technology officer, Martin Stumpe, up until Bertram’s departure in 2027. A trained physician, Fischer joined Siemens in 2009 and has held leadership roles across cardiovascular care and CT since 2019. 

Sonja Wehsely also is taking over as head of the Europe, Middle East and Africa segment effective June 1. She replaces Bernd Ohnesorge, who has led the business for eight years but now plans to “step aside for personal reasons,” Montag said. Wehsely joined Siemens Healthineers in 2017 and currently leads one of the “largest and most complex” zones in this geography, spanning 30 countries. And finally, Elaine Becraft will assume the role of chief human resources officer on Oct. 1. She first joined Siemens in 2022 and currently leads HR for diagnostics. 

The moves come as the larger Siemens umbrella company works toward a spin-off of the Healthineers business into a separate segment. Leaders said in April that they anticipate holding a shareholder vote on the transaction in February. Siemens and its Healthineers segment said they’ve made “substantial progress” in preparing for the spin-off, including reviewing all key contractual relationships.